New diabetes clinical trial: A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions
Published on: 2026-06-12T04:00:00Z Conditions : Liver Cancer Interventions : Drug: Immune Checkpoint Inhibitors Sponsors : Harbin Medical University; Liaoning Cancer Hospital & Institute; China-Japan Union Hospital, Jilin University; First Affiliated Hospital of Harbin Medical University; The Second Affiliated Hospital of Harbin Medical University Active, not recruiting https://ift.tt/b54nTz1